文献速递妇科生殖医学

腹腔镜确诊子宫内膜异位症与长期COVID-19的关联:一项前瞻性队列研究

Association of laparoscopically-confirmed endometriosis with long COVID-19: a prospective cohort study.
PubMed 文献 · Am J Obstet Gynecol · 2023-03-25

该研究随访46,579名女性,其中3650例自报SARS-CoV-2感染,386例(10.6%)有腹腔镜确诊子宫内膜异位症史,1598例(43.8%)报告长期COVID-19症状。有子宫内膜异位症史者发生长期COVID-19的风险升高22%(校正风险比1.22,95%CI 1.05-1.42)。作者认为有子宫内膜异位症史者长期COVID-19风险可能轻度增加。

要点

  • 有腹腔镜确诊子宫内膜异位症史的女性发生长期COVID-19的风险升高22%(校正RR 1.22,95%CI 1.05-1.42)。
  • 当长期COVID-19定义为症状持续≥8周时关联更强(RR 1.28,95%CI 1.09-1.50)。
  • 在长期COVID-19患者中,有子宫内膜异位症者平均报告多1个长期症状。

核心结论

  • 研究结果提示,有子宫内膜异位症史者长期COVID-19风险可能轻度增加。
  • 作者建议医疗保健提供者在处理SARS-CoV-2感染后持续症状患者时了解其子宫内膜异位症病史。
  • 作者提出未来研究应探究这些关联背后的潜在生物学通路。

研究设计与样本

  • 前瞻性队列研究,随访来自护士健康研究II和护士健康研究3两个正在进行的前瞻性队列的46,579名女性。
  • 研究对象参与了2020年4月至2022年11月实施的一系列COVID-19相关调查。
  • 子宫内膜异位症的腹腔镜诊断在大流行前(1993-2020年)的主队列问卷中前瞻性记录,具有高效度。
  • SARS-CoV-2感染(经抗原、聚合酶链反应或抗体检测确认)和长期COVID-19症状(≥4周,由美国疾病控制与预防中心定义)在随访期间自报。
  • 在SARS-CoV-2感染者中,拟合泊松回归模型评估子宫内膜异位症与长期COVID-19症状风险的关联,并校正人口学特征、体重指数、吸烟状态、不孕史和慢性病史等潜在混杂变量。

主要发现

  • 在3650名自报SARS-CoV-2感染的女性中,386名(10.6%)有腹腔镜确诊的子宫内膜异位症史,1598名(43.8%)报告长期COVID-19症状。
  • 大多数女性为非西班牙裔白人(95.4%),中位年龄59岁(四分位距44-65)。
  • 有腹腔镜确诊子宫内膜异位症史的女性发生长期COVID-19的风险比从未诊断子宫内膜异位症者高22%(校正风险比1.22,95%CI 1.05-1.42)。
  • 当长期COVID-19定义为症状持续≥8周时,关联更强(风险比1.28,95%CI 1.09-1.50)。
  • 按年龄、不孕史或子宫肌瘤共病分层,子宫内膜异位症与长期COVID-19的关联无统计学显著差异;但存在提示性趋势,<50岁女性关联可能更强(<50岁:风险比1.37,95%CI 1.00-1.88;≥50岁:风险比1.19,95%CI 1.01-1.41)。

临床怎么用

  • 作者建议医疗保健提供者在处理SARS-CoV-2感染后持续症状患者时了解其子宫内膜异位症病史。
  • 研究结果提示有子宫内膜异位症史者长期COVID-19风险可能轻度增加。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Women are at greater risk than men of developing chronic inflammatory conditions and "long COVID." However, few gynecologic health risk factors for long COVID-19 have been identified. Endometriosis is a common gynecologic disorder associated with chronic inflammation, immune dysregulation, and comorbid presentation with autoimmune and clotting disorders, all of which are pathophysiological mechanisms proposed for long COVID-19. Therefore, we hypothesized that women with a history of endometriosis may be at greater risk of developing long COVID-19. OBJECTIVE: This study aimed to investigate the association between history of endometriosis before SARS-CoV-2 infection and risk of long COVID-19. STUDY DESIGN: We followed 46,579 women from 2 ongoing prospective cohort studies-the Nurses' Health Study II and the Nurses' Health Study 3-who participated in a series of COVID-19-related surveys administered from April 2020 to November 2022. Laparoscopic diagnosis of endometriosis was documented prospectively in main cohort questionnaires before the pandemic (1993-2020) with high validity. SARS-CoV-2 infection (confirmed by antigen, polymerase chain reaction, or antibody test) and long-term COVID-19 symptoms (≥4 weeks) defined by the Centers for Disease Control and Prevention were self-reported during follow-up. Among individuals with SARS-CoV-2 infection, we fit Poisson regression models to assess the associations between endometriosis and risk of long COVID-19 symptoms, with adjustment for potential confounding variables (demographics, body mass index, smoking status, history of infertility, and history of chronic diseases). RESULTS: Among 3650 women in our sample with self-reported SARS-CoV-2 infections during follow-up, 386 (10.6%) had a history of endometriosis with laparoscopic confirmation, and 1598 (43.8%) reported experiencing long COVID-19 symptoms. Most women were non-Hispanic White (95.4%), with a median age of 59 years (interquartile range, 44-65). Women with a history of laparoscopically-confirmed endometriosis had a 22% greater risk of developing long COVID-19 (adjusted risk ratio, 1.22; 95% confidence interval, 1.05-1.42) compared with those who had never been diagnosed with endometriosis. The association was stronger when we defined long COVID-19 as having symptoms for ≥8 weeks (risk ratio, 1.28; 95% confidence interval, 1.09-1.50). We observed no statistically significant differences in the relationship between endometriosis and long COVID-19 by age, infertility history, or comorbidity with uterine fibroids, although there was a suggestive trend indicating that the association may be stronger in women aged <50 years (<50 years: risk ratio, 1.37; 95% confidence interval, 1.00-1.88; ≥50 years: risk ratio, 1.19; 95% confidence interval, 1.01-1.41). Among persons who developed long COVID-19, women with endometriosis reported on average 1 additional long-term symptom compared with women without endometriosis. CONCLUSION: Our findings suggest that those with a history of endometriosis may be at modestly increased risk for long COVID-19. Healthcare providers should be aware of endometriosis history when treating patients for signs of persisting symptoms after SARS-CoV-2 infection. Future studies should investigate the potential biological pathways underlying these associations.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Wang S, Farland LV, Gaskins AJ, et al. Association of laparoscopically-confirmed endometriosis with long COVID-19: a prospective cohort study. Am J Obstet Gynecol. 2023. PMID: 36972892. doi:10.1016/j.ajog.2023.03.030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。